Drugs that treat new hepatitis C, cheap

Two scientists Sunil Shaunak and Steve Brocchoni from London University of Pharmacy, UK have successfully researched new methods of producing drugs to treat hepatitis C, cheaper than other major pharmaceutical companies.

By modifying the molecular structure of the existing version of the hepatitis C drug, the two researchers successfully studied new hepatitis C drugs to provide affordable drugs for developing countries. development.

A form of hepatitis C blood infection (Photo BBC, VNN)

They have partnered with an Indian Pharmaceutical Company to produce this new drug. At the same time, they have registered exclusive rights to manufacture for 20 years and ask the University or Charity Organizations to hold the copyright, not to other major pharmaceutical suppliers.

The British Government, the Chamber of Commerce and Industry and other Charities have funded research and production of this new drug.

No cover by sugar

The most effective hepatitis C virus medication currently on the market is made from the natural molecules of the hepatitis C virus. Outside the tablet is covered with a layer of sugar. This protective line will protect against the effects of all other drugs that adhere to the medication.

However, the new drug for hepatitis C treatment, even without the sugar covering the entire tablet, is still protected.

Now scientists are planning to develop a consumer market to avoid the expensive expensive hepatitis C treatment available with this new, inexpensive drug.

Prof. Shaunak said: " We have successfully researched cheap drugs for treatment of hepatitis C by new methods and we also have to find a reasonable delivery method to consumers. Our research aims to cure poor patients in developing countries ".

Hepatitis C is a viral disease and can cause serious damage to the liver.Discovered in 1989, the virus spreads through blood like hepatitis B, but rarely passes through sex.Hepatitis C is often referred to as a " silent disease " because many patients who carry the virus have no symptoms and do not feel sick.

According to the World Health Organization, it is estimated that there are 170 million people worldwide are sick. There is currently no vaccine to prevent patients from hepatitis C. However, once infected and infected with hepatitis C, there is treatment.

Hepatitis C is often transmitted through blood, sex, mother to child during pregnancy (rare).

According to Health.com

According to him, the current price of treatment for hepatitis C is only for people with economic conditions to afford medical treatment.

Providers and patients all benefit

Currently, in science there are many advanced methods for effective treatment of hepatitis C. These methods are often studied in Universities or Charities and patents sold to pharmaceutical companies that supply drugs to the market.

According to GS. Shaunak, the new treatment for hepatitis C, will be provided independently to consumers and completely competitive with other pharmaceutical companies.

The purpose of this job is that both providers get direct profit and the patient gets the cheap price. A spokesman for the British Pharmaceutical Industry said it would approve the new drug and list a face value before the drug was marketed.

If this is successful, the UK Pharmaceutical Industry will invest in a drug production line that will attract the developing countries themselves, distribute and use it.

At the same time, he also pledged that pharmaceutical companies would ensure treatments for patients in developing countries are free to choose, not to necessarily necessarily treat the new drug.

In addition, Roche Pharmaceuticals, which is a provider of hepatitis C medicine, said it would refine the round pill model to help patients distinguish each brand's drug.

mystical gem